---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-105148"
form_type: "8-K"
ticker: "ITRMF"
cik: "0001659323"
company_name: "Iterum Therapeutics plc"
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:24:39.870915+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Iterum Therapeutics announces $5M registered direct offering of ordinary shares and pre-funded warrants

## Summary
- Gross proceeds of $5.0M from sale of 5,555,556 shares/warrants at $0.90 each.
- Net proceeds ~$4.2M after fees; H.C. Wainwright acting as placement agent.
- Funding to support pre-commercialization of ORLYNVAH and strategic process, cash runway into 2026.
- Offering expected to close April 30, 2025, subject to customary conditions.
- Pre-funded warrants exercisable at $0.01 per share with 9.99% beneficial ownership cap.

## SEC filing metadata
- accession: 0001193125-25-105148
- form_type: 8-K
- ticker: ITRMF
- cik: 0001659323
- company_name: Iterum Therapeutics plc
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/0001193125-25-105148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659323/000119312525105148/d803323d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-105148
- JSON: https://secwatch.observer/filing/0001193125-25-105148.json
- Plain text: https://secwatch.observer/filing/0001193125-25-105148.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.